A carregar...
Regulating pharmaceutical companies’ financial largesse
Nissanholtz-Gannot and Yenkellevich (NGY) explore the impact of a 2010 amendment to the Israeli National Health Insurance Law that requires annual reporting of payments from pharmaceutical companies (PCs) to doctors and healthcare organizations. The amendment was adopted to ensure transparency and t...
Na minha lista:
| Publicado no: | Isr J Health Policy Res |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5952623/ https://ncbi.nlm.nih.gov/pubmed/29759077 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13584-018-0220-5 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|